T-cell Lymphoblastic Lymphoma
9 clinical trials · Condition
◉ Watch T-cell Lymphoblastic Lymphoma
| Record | Firm | Date |
|---|---|---|
| XmAb18968 (CD3-CD38) in Relapsed or Refractory Acute Leukemia and T Cell Lymphoblastic Leukemia (NCT05038644) | Ehab L Atallah | 2022-02-02 |
| A Study of LY3039478 in Combination With Dexamethasone in Participants With T-ALL/T-LBL (NCT02518113) | Eli Lilly and Company | 2015-10-01 |
| Pilot Study of Expanded, Donor Natural Killer Cell Infusions for Refractory Non-B Lineage Hematologic Malignancies and Solid Tumors (NCT00640796) | St. Jude Children's Research Hospital | 2008-09-01 |
Track T-cell Lymphoblastic Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.